(44- 20) 74 18 84 00 Fax (44- 20) 74 18 86 68 E- mail: mail@ emea. europa. eu http: // www. emea. europa. eu ©EMEA 2007 Reproduction and/ or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Derfor blev det ikke påvist i undersøgelsen, at Genasense havde en effekt i behandlingen af melanom.
(44-20) 74 18 84 00 Fax (44-20) 74 18 86 68 E-Mail: mail@emea.europa.eu http://www.emea.europa.eu ©EMEA 2007 Reproduction and/or distribution of this document is authorised for non commercial purposes only provided the EMEA is acknowledged Was waren die größten Bedenken, die den CHMP zur Versagung der Genehmigung des Inverkehrbringens veranlasst haben?